Chronic obstructive pulmonary disease

Active Ingredient: Budesonide

Indication for Budesonide

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
Therapeutic intent: Curative procedure

For this indication, competent medicine agencies globally authorize below treatments:

0.5-1 mg twice daily

For:

Dosage regimens

Respiratory (Inhalation), between 0.5 milligrams budesonide and 1 milligrams budesonide, 2 times daily.

Detailed description

The dose should be given twice daily.

Initial dosage

The initial dose should be tailored to the severity of the disease and thereafter should be adjusted on an individual basis. The following doses are recommended but the minimum effective dose should always be sought:

Adults (including the elderly): 0.5-2 mg daily. In very severe cases the dosage may be increased further.

Maintenance dose

The maintenance dose should be adjusted to meet the requirements of the individual patient taking account of the severity of the disease and the clinical response of the patient. When the desired clinical effect has been obtained, the maintenance dose should be reduced to the minimum required for control of the symptoms.

0.5-2 mg daily

For:

Dosage regimens

Respiratory (Inhalation), between 0.5 milligrams budesonide and 1 milligrams budesonide, 2 times daily. The maximum allowed total dose is 2 milligrams budesonide daily.

Detailed description

The dose should be given twice daily.

Initial dosage

The initial dose should be tailored to the severity of the disease and thereafter should be adjusted on an individual basis. The following doses are recommended but the minimum effective dose should always be sought:

Children/adolescents over 12 years of age: 0.5-2 mg daily. In very severe cases the dosage may be increased further.

Maintenance dose

The maintenance dose should be adjusted to meet the requirements of the individual patient taking account of the severity of the disease and the clinical response of the patient. When the desired clinical effect has been obtained, the maintenance dose should be reduced to the minimum required for control of the symptoms.

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.